SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: erippetoe11/21/2024 11:18:09 AM
2 Recommendations

Recommended By
jhcimmu
mistermj

   of 63305
 
"Cassava released a few k4s today and a new name popped up. K4s are used to announce things like stock compensation for leadership, buying/selling of stock by insiders, ect. While there hasn't been an announcement from Cassava yet, it appears they hired Landen Jaren as Chief Clinical Dev. Officer. I'm pretty sure she's this linked-in profile based on her experience in early AD at Biogen."

Interesting thread. reddit.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News